Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin

BACKGROUND: Lung cancer is the leading cause of cancer deaths in the world. The major histopathological subtype of lung cancer is non-small cell lung cancer (NSCLC). Platinum-based therapy is the standard of care for patients with advanced stage NSCLC. However, even with treatment, most patients wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapperman, Heather E., Goyeneche, Alicia A., Telleria, Carlos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238342/
https://www.ncbi.nlm.nih.gov/pubmed/30479564
http://dx.doi.org/10.1186/s12935-018-0683-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238342/
https://www.ncbi.nlm.nih.gov/pubmed/30479564
http://dx.doi.org/10.1186/s12935-018-0683-z

Ejemplares similares